Categories AlphaGraphs, Earnings, Finance

Citigroup reports revenue and earnings growth for Q3 FY25; results beat estimates

Banking giant Citigroup Inc. (NYSE: C) on Tuesday said its third-quarter FY25 revenues and earnings increased year-over-year. The numbers also exceeded Wall Street’s estimates.

Citigroup Q3 2025 Earnings

Net income was $3.8 billion or $1.86 per diluted share in the third quarter, compared to $3.2 billion or $1.51 per share in the year-ago quarter. The bottom line exceeded analysts’ expectations. Third-quarter revenues rose to $22.1 billion from $20.2 billion in the prior year quarter and beat estimates.

The bank’s end-of-period loans were $734 billion, up 7% compared to the prior-year period, aided by higher loans in Markets, Services, and Branded Cards.

The relentless execution of our strategy is delivering stronger business performance quarter after quarter and improving our returns. The cumulative effect of what we have done over the past years – our transformation, our refreshed strategy, our simplification – have put Citi in a materially different place in terms of our ability to compete,” Citigroup’s CEO Jane Fraser said.

Prior Performance

  • Citigroup Q1 2025 Earnings Infographic
  • Citigroup Q4 2024 earnings infographic
  • Citigroup Q3 2024 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Citigroup set to report Q4 2025 earnings. Here’s what to expect

Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the

Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon

Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top